Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CASAD for Severe Diarrhea in Cancer Patients
NCT02018653Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Dec 2013
- Primary completion
- Aug 2014
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in diarrhea comparing Calcium Alumina-Silicate (CASAD) with Placebo (2 arms). Primary endpoint: Time to Resolution of Diarrhea at 6 days. Started Dec 2013; status: terminated.
02
Drugs
calcium aluminosilicate
03
Conditions
diarrhea
Beyond the preview
Go deeper on NCT02018653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02018653.